Embremma 0.5mg Injection is a chemotherapy drug that contains the active substance eribulin, which belongs to the class of antineoplastic agents. Embremma 0.5mg Injection is used in adults for advanced breast cancer or liposarcoma (a type of cancer originating from fat tissue) when other treatments have stopped working.

It is not recommended to take Embremma 0.5mg Injection if you are allergic to Eribulin or any of its other ingredients. Consult your doctor if you believe this applies to you. It is not recommended for children and adolescents younger than 18 years since the effects of Embremma 0.5mg Injection in this population are unknown. Before starting the treatment, you should inform your physician if you have fever, infections, liver, or heart problems. Before starting the treatment, give a detailed account of your medical history and medications.

• Advanced breast cancer
• Liposarcoma

Eribulin stops the growth and spread of cancer cells, specifically targeting the growth phase of microtubules, which are structures that help cells divide. It prevents them from growing without interfering with their shrinking phase. Additionally, it causes tubulin, a protein essential for cell division, to clump together in a way that disrupts cell division. This ultimately leads to the blockage of the cell cycle (G2/M phase), disrupting the formation of structures necessary for cell division (mitotic spindles) and triggering cell death through apoptosis.

Inform your doctor about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Embremma 0.5mg Injection and reduce effectiveness by causing undesirable side effects.

• Store Embremma 0.5mg Injection at 25°C.
• Keep it in its original packaging.
• Protect it from light and moisture.
• Keep it out of the reach of children and pets.

Embremma 0.5mg Injection will be given to you by your healthcare provider. It is injected directly into a vein (intravenous infusion) in a cycle. Your healthcare provider determines the dose, duration, and frequency based on your age, body weight, and severity of your condition. If you forget or miss your Embremma 0.5mg Injection cycle dose, make another appointment as soon as possible. Do not wait until your next planned visit. Do not stop the treatment without physician advice.

Side effects are unwanted symptoms that occur due to medicines. Even though all drugs cause side effects, not everyone gets them.

Serious

• Sepsis (severe infection)
• Severe allergic reaction
• Serious skin conditions (Stevens-Johnson syndrome)

Common

• Decrease in the number of white blood cells or red blood cells
• Tiredness or weakness
• Nausea, vomiting, constipation, diarrhea
• Numbness, tingling or prickling sensations
• Fever
• Loss of appetite, weight loss
• Difficulty breathing, cough
• Pain in the joints, muscles, and back
• Headache
• Hair loss

Your doctor will monitor your liver function via blood tests and assess your heart function before and during treatment. If you are a woman who could become pregnant, ensure reliable birth control while taking Embremma 0.5mg Injection and for at least three months after stopping it. Consult your doctor for guidance on alternative contraception methods to avoid pregnancy during this treatment. Talk to your oncologist if you need dental treatment. Always tell your dentist you are having cancer treatment. This treatment can affect fertility in men and women. If you are worried about this, it is important to talk with your doctor before you start treatment.

If you experience diarrhea while taking Embremma 0.5mg Injection, try to drink at least 2 liters of fluids daily and avoid alcohol, caffeine, milk products, and high-fat and high-fiber foods. If constipation occurs, increase your fluid intake, consume high-fiber foods, and engage in regular gentle exercise. Contact the hospital for advice; your doctor may prescribe laxatives to help constipation. If you notice a loss of appetite, don't worry if it lasts for a day or two, but if it persists or if you're losing weight, inform your nurse or dietitian for guidance. They may recommend supplements, dietary changes, or adjustments to eating habits to address these issues.

1. Eisai Europe Limited, Electronic medicines compendium (EMC), [Revised on Jan 2023] [Accessed on Feb 2024], https://www.medicines.org.uk/emc/files/pil.4517.pdf
2. Genentech, Inc, US Food and Drug Administration (FDA), [Revised on Jan 2016], [Accessed on Feb 2024], https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/201532s015lbl.pdf
3. Goodman & Gilman's Pharmacological Basis of Therapeutics, Pharmacotherapy of neoplastic drugs, 13th edition, 2018, 1187.